Here are seven articles published by Becker's Hospital Review in the past week that offer insight on the pharmaceutical industry, top priorities for supply chain leaders in 2017 and more.
1. Johnson & Johnson inks $30B deal with Actelion
New Brunswick, N.J.-based Johnson & Johnson will acquire Swiss biotechnology company Actelion for $30 billion.
2. ACA repeal and replace will include action on drug prices, Spicer says
President Donald Trump plans to tackle high drug prices through his ACA replacement, White House press secretary Sean Spicer said during a Monday press briefing.
3. Martin Shkreli calls out industry price hikes with new 'Pharma Skeletons' website
Martin Shkreli, former CEO of Turing Pharmaceuticals, is targeting the drug industry with a new website highlighting major issues of individual drugmakers.
4. 4 top priorities for supply chain leaders in 2017
Louisville, Colo.-based Global Healthcare Exchange polled 50 supply chain leaders from across the country on their main priorities and outcomes for the healthcare supply chain in 2017.
5. Trump seeks to bring supply chains back to US with 'major' border tax
President Donald Trump met with a group of Fortune 500 CEOs at the White House Monday and warned them that any move to shift manufacturing processes overseas will be met with a "substantial border tax."
6. Amid heavy criticism of drug prices, pharma group launches ad campaign to improve image
The pharmaceutical industry's major lobbying group has launched its largest-ever ad campaign designed to improve the industry's public image following heated criticism over rising drug prices.
7. 3 ways to improve supplier relationships
Investing time and resources to assess and optimize supplier relationships can greatly benefit an organization, Nigel Crunden, business specialist at Office Depot, wrote in an article for Supply Chain Digital.
More articles on supply chain:
Tom Price open to CMS negotiating drug prices
6 quotes from Dr. Joseph Gulfo — Trump's potential pick for FDA commissioner
Johnson & Johnson inks $30B deal with Actelion